adapalene NDC 0472-0126

NDC codes

FDA NDC Directory

Product NDC (as listed)0472-0126Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00472-0126Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0472-0126-45	00472012645	1 TUBE in 1 CARTON (0472-0126-45) / 45 g in 1 TUBEMarketed from Oct 27, 2014

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): adapalene
Generic name (nonproprietary): adapalene
Active ingredients: Adapalene — 3 mg/g
Dosage form: Gel
Route: Topical
Labeler: Actavis Pharma, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 201000
Marketing start: Oct 27, 2014
Listing expires: Dec 31, 2026
Other FDA classes: Retinoids (Chemical structure)
Identifiers: Product ID 0472-0126_9bada4fd-f276-4355-bed1-ae5eee087c95SPL ID 9bada4fd-f276-4355-bed1-ae5eee087c95SPL set ID aacd5ec4-e2fa-460e-aaae-a0aba5c052e5RxCUI 722111UNII 1L4806J2QF
Pharmacologic class: Retinoid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400472012645 followed by a unit qualifier and the quantity

Package 00472-0126-45. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 30, 2024.

Indications (excerpt from the label)

Adapalene gel is indicated for the topical treatment of acne vulgaris in patients 12 years of age and older. Adapalene Gel is a retinoid, indicated for the topical treatment of acne vulgaris in patients 12 years of age and older. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)